Spasgan-M 50mg/250mg Tablet
Marketer
Osper Formulations Pvt Ltd
Salt Composition
Drotaverine (50mg) + Mefenamic Acid (250mg)
Overview Spasgan-M 50mg/250mg Tablet
Abdominal pain relief is provided by the combined medication Spasgan-M 50mg/250mg tablets. This formulation effectively alleviates abdominal pain, bloating, discomfort, and cramping through muscle relaxation in the stomach and intestines. It also inhibits pain-inducing chemical signals. As directed by your physician, take Spasgan-M 50mg/250mg tablets with food, following the prescribed dosage and duration. Dosage is individualized based on your condition and response. Continue treatment as recommended; premature discontinuation might lead to symptom recurrence and worsening condition. Inform your healthcare provider about all other medications you're using, as interactions may occur. Common side effects, often transient, include diarrhea, nausea, vomiting, stomach upset, dry mouth, appetite loss, thirst, and heartburn. Report any concerning side effects immediately. Dizziness and drowsiness are possible; avoid driving or mentally demanding tasks until the drug's effects are known. Alcohol should be avoided due to increased dizziness risk. Consult your doctor prior to use if pregnant, planning pregnancy, breastfeeding, or having liver or kidney disease for appropriate dosage adjustments.
Primary Ingredients of Spasgan-M 50mg/250mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Spasgan-M 50mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Spasgan-M 50mg/250mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. The Spasgan-M 50mg/250mg Tablet should be administered with a meal.
Common Side effects of Spasgan-M 50mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Spasgan-M 50mg/250mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Spasgan-M 50mg/250mg tablets with food.
How Spasgan-M 50mg/250mg Tablet works:
Each Spasgan-M 50mg/250mg tablet combines drotaverine and mefenamic acid to alleviate abdominal cramping and discomfort. Drotaverine, an antispasmodic agent, targets abdominal smooth muscle spasms, easing contractions. Mefenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for abdominal pain and swelling.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Spasgan-M 50mg/250mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Spasgan-M 50mg/250mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against the risks before prescribing this medication. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
Data on Spasgan-M 50mg/250mg Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Spasgan-M 50mg/250mg Tablets, a potential side effect of the medication, as dizziness can occur.
KidneyCAUTION
Patients with impaired kidney function should use Spasgan-M 50mg/250mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Spasgan-M 50mg/250mg tablets are contraindicated in individuals with severely compromised renal function.
LiverCAUTION
Patients with liver impairment should use Spasgan-M 50mg/250mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Spasgan-M 50mg/250mg Tablet :
Should you forget a Spasgan-M 50mg/250mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Spasgan-M 50mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently